MX9205792A - Derivados novedosos de asa-androstan 178-substituidos - Google Patents

Derivados novedosos de asa-androstan 178-substituidos

Info

Publication number
MX9205792A
MX9205792A MX9205792A MX9205792A MX9205792A MX 9205792 A MX9205792 A MX 9205792A MX 9205792 A MX9205792 A MX 9205792A MX 9205792 A MX9205792 A MX 9205792A MX 9205792 A MX9205792 A MX 9205792A
Authority
MX
Mexico
Prior art keywords
carbon atoms
fen
formula
group
substituted
Prior art date
Application number
MX9205792A
Other languages
English (en)
Spanish (es)
Inventor
Michel Biollaz
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX9205792A publication Critical patent/MX9205792A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX9205792A 1991-10-09 1992-10-08 Derivados novedosos de asa-androstan 178-substituidos MX9205792A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH297891 1991-10-09

Publications (1)

Publication Number Publication Date
MX9205792A true MX9205792A (es) 1993-08-01

Family

ID=4245915

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205792A MX9205792A (es) 1991-10-09 1992-10-08 Derivados novedosos de asa-androstan 178-substituidos

Country Status (19)

Country Link
US (2) US5304562A (https=)
EP (1) EP0538192B1 (https=)
JP (1) JPH05213989A (https=)
KR (1) KR930007969A (https=)
AT (1) ATE152121T1 (https=)
AU (1) AU657579B2 (https=)
CA (1) CA2080054A1 (https=)
DE (1) DE59208383D1 (https=)
DK (1) DK0538192T3 (https=)
ES (1) ES2101073T3 (https=)
FI (1) FI924529A7 (https=)
GR (1) GR3024013T3 (https=)
HU (1) HUT62600A (https=)
IL (1) IL103361A (https=)
MX (1) MX9205792A (https=)
NO (1) NO923911L (https=)
NZ (1) NZ244640A (https=)
TW (1) TW263513B (https=)
ZA (1) ZA927747B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives
WO1993023039A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors
CZ283894A3 (en) * 1992-05-20 1995-09-13 Merck & Co Inc 7beta-substituted 4-aza-5alpha-cholestanones, their use for the preparation of pharmaceutical preparations and pharmaceutical compositions containing thereof
GB9210880D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Corp Compounds
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives
HU212459B (en) * 1992-10-02 1996-06-28 Richter Gedeon Vegyeszet Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them
EP0663924B1 (en) * 1992-10-06 2001-02-14 Merck & Co. Inc. 17-beta-carboxanilides of 4-aza-5-alpha-androstan-3-ones as 5-alpha-reductase inhibitors
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5470976A (en) * 1994-09-07 1995-11-28 Merck & Co., Inc. Process for the stereoselective reduction of steroid enelactams
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
US5656613A (en) * 1995-01-04 1997-08-12 Merck & Co., Inc. Treatment of hyperandrogenic conditions
US6001844A (en) * 1995-09-15 1999-12-14 Merck & Co., Inc. 4-Azasteroids for treatment of hyperandrogenic conditions
EP0859761A4 (en) * 1995-09-15 2000-01-26 Merck & Co Inc 4-AZASTEROIDS FOR TREATING HYPERANDROGEN STATES
US5998427A (en) * 1998-05-14 1999-12-07 Glaxo Wellcome Inc. Androstenones
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
IL74365A (en) * 1984-02-27 1990-07-26 Merck & Co Inc 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it
US5049562A (en) * 1984-02-27 1991-09-17 Merck & Co., Inc. 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
ATE78827T1 (de) * 1986-11-20 1992-08-15 Merck & Co Inc Topisches arzneimittel enthaltend 17-beta-methoxy-carbonyl-4-methyl-4-aza-5-alpha androst-1-en-3- one.
US4888336A (en) * 1987-01-28 1989-12-19 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
DE3888378T2 (de) * 1987-04-03 1994-09-29 Merck & Co Inc Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
WO1991000732A1 (en) * 1989-07-07 1991-01-24 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
CA2023157A1 (en) * 1989-08-21 1991-02-22 Gary H. Rasmusson 17 beta-acyl-4-aza-5 alpha-androst-1-ene-3-ones as 5 alpha-reductase inhibitors
US5120847A (en) * 1990-08-27 1992-06-09 Merck & Co., Inc. Process for iodinating or brominating the α-methylenic carbon of a secondary amide
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives

Also Published As

Publication number Publication date
IL103361A0 (en) 1993-03-15
EP0538192A1 (de) 1993-04-21
ES2101073T3 (es) 1997-07-01
NO923911D0 (no) 1992-10-08
IL103361A (en) 1997-06-10
ATE152121T1 (de) 1997-05-15
KR930007969A (ko) 1993-05-20
AU2626192A (en) 1993-04-22
US5304562A (en) 1994-04-19
CA2080054A1 (en) 1993-04-10
FI924529A0 (fi) 1992-10-07
US5378710A (en) 1995-01-03
HUT62600A (en) 1993-05-28
TW263513B (https=) 1995-11-21
GR3024013T3 (en) 1997-10-31
NO923911L (no) 1993-04-13
EP0538192B1 (de) 1997-04-23
NZ244640A (en) 1994-12-22
AU657579B2 (en) 1995-03-16
DK0538192T3 (da) 1997-05-20
DE59208383D1 (de) 1997-05-28
FI924529A7 (fi) 1993-04-10
JPH05213989A (ja) 1993-08-24
HU9203189D0 (en) 1992-12-28
ZA927747B (en) 1993-04-13

Similar Documents

Publication Publication Date Title
MX9205792A (es) Derivados novedosos de asa-androstan 178-substituidos
DE3582452D1 (de) Substituierte bicyclische verbindungen.
PE2896A1 (es) Derivado de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamento
ES8603455A1 (es) Un metodo para preparar derivados de piperazina
ES2111654T3 (es) Derivados de piperazina como antagonistas de 5-ht1a.
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
ES2094204T3 (es) Derivados de piperazina.
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
FI861410A0 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva aminopropanolderivat.
ES2091249T3 (es) Analogos de iludina utilizables como agentes antitumorales.
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
ES2001875A6 (es) Procedimiento para preparar nuevos derivados de aminoacidos
IT1196423B (it) Benzotiazolin-composti
DK384485D0 (da) 1,6-naphthyridinderivater med kardilaterende virkning
ES2032482T3 (es) Derivados del bencilidenamino-, bencilamino- y benzoilamino-imidazol y su empleo como medicamentos. (reserva del art. 167.2 cpe).
MX9204138A (es) Compuestos ditiano, procedimiento para su obtencion y medicamentos que los contienen
ES2062860T3 (es) Composicion farmaceutica para la mejoria de la disuria.
ES2088567T3 (es) Empleo de derivados de la 2-iminotioazolidin-4-ona como nuevos productos activos para medicamentos.
ES2094132T3 (es) Uso de derivados de xantina contra la ulcera peptica.
FI822706A0 (fi) Foerfarande foer framstaellning av farmakologiskt aktiva heteroaryloxipropanolaminer
TW366283B (en) Compounds for treatment of arrhythmia
ES2063305T3 (es) Derivados de bifenilo, procedimiento para la preparacion de los mismos e intermedios para los mismos.
NO944476L (no) Tetrahydro - og perhydro-isokinolinderivater og terapeutiske midler inneholdende dem
ES2183636T3 (es) 4'-sustituido-4', 5'-dihidropsoralenos y sus usos terapeuticos.
GB1441686A (en) Substituted n-acyl-n-3-amino-2-cyano-acryloyl-formamidrazones